Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Kerber

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
The American Journal of Cardiology|July 5, 2014
Impact of long-term statin pretreatment on myocardial damage in ST elevation myocardial infarction (from the AIDA STEMI CMR Substudy)Georg Fuernau, Ingo Eitel, Jochen Wöhrle, et al.
Journal of the American College of Cardiology|March 8, 2013
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trialIngo Eitel, Jochen Wöhrle, Henning Suenkel, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 26, 2025
Determinants of recovery from right ventricular dysfunction after transcatheter edge-to-edge tricuspid valve repairFelix Ausbuettel, Christian Waechter, Ulrich Luesebrink, et al.
JACC. Advances|February 15, 2025
The Impact of Frailty on VARC-3 Integrated Outcomes in Patients Undergoing Transcatheter Aortic Valve ReplacementDaijiro Tomii, Jonas Lanz, Dik Heg, et al.
JAMA Network Open|December 9, 2025
Obstructive Coronary Artery Disease and Health Status in Transcatheter Aortic Valve Replacement: A Post Hoc Analysis of the SCOPE I Randomized Clinical TrialDaijiro Tomii, Jonas Lanz, Holger Thiele, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 1, 2025
Clinical and health status after permanent pacemaker implantation in patients undergoing transcatheter aortic valve replacement: Insights from the SCOPE I randomized trialMasaaki Nakase, Daijiro Tomii, Jonas Lanz, et al.
American Heart Journal|April 6, 2010
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trialHolger Thiele, Jochen Wöhrle, Petra Neuhaus, et al.
Lancet (London, England)|October 2, 2019
Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trialJonas Lanz, Won-Keun Kim, Thomas Walther, et al.
Journal of the American College of Cardiology|January 20, 2010
Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registryKrischan D Sjauw, Thomas Konorza, Raimund Erbel, et al.
Circulation. Cardiovascular Interventions|July 7, 2023
Final 3-Year Outcomes of a Randomized Trial Comparing a Self-Expanding to a Balloon-Expandable Transcatheter Aortic ValveJonas Lanz, Helge Möllmann, Won-Keun Kim, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The American Journal of Cardiology|July 5, 2014
Impact of long-term statin pretreatment on myocardial damage in ST elevation myocardial infarction (from the AIDA STEMI CMR Substudy)Georg Fuernau, Ingo Eitel, Jochen Wöhrle, et al.
Journal of the American College of Cardiology|March 8, 2013
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trialIngo Eitel, Jochen Wöhrle, Henning Suenkel, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 26, 2025
Determinants of recovery from right ventricular dysfunction after transcatheter edge-to-edge tricuspid valve repairFelix Ausbuettel, Christian Waechter, Ulrich Luesebrink, et al.
JACC. Advances|February 15, 2025
The Impact of Frailty on VARC-3 Integrated Outcomes in Patients Undergoing Transcatheter Aortic Valve ReplacementDaijiro Tomii, Jonas Lanz, Dik Heg, et al.
JAMA Network Open|December 9, 2025
Obstructive Coronary Artery Disease and Health Status in Transcatheter Aortic Valve Replacement: A Post Hoc Analysis of the SCOPE I Randomized Clinical TrialDaijiro Tomii, Jonas Lanz, Holger Thiele, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 1, 2025
Clinical and health status after permanent pacemaker implantation in patients undergoing transcatheter aortic valve replacement: Insights from the SCOPE I randomized trialMasaaki Nakase, Daijiro Tomii, Jonas Lanz, et al.
American Heart Journal|April 6, 2010
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trialHolger Thiele, Jochen Wöhrle, Petra Neuhaus, et al.
Lancet (London, England)|October 2, 2019
Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trialJonas Lanz, Won-Keun Kim, Thomas Walther, et al.
Journal of the American College of Cardiology|January 20, 2010
Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registryKrischan D Sjauw, Thomas Konorza, Raimund Erbel, et al.
Circulation. Cardiovascular Interventions|July 7, 2023
Final 3-Year Outcomes of a Randomized Trial Comparing a Self-Expanding to a Balloon-Expandable Transcatheter Aortic ValveJonas Lanz, Helge Möllmann, Won-Keun Kim, et al.
Pageof 9